| Expression pattern: |
UP |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
Marks a subgroup of immunogenic Asian ICC characterized by T cell exhaustion and neutrophil extracellular traps; potential liquid biopsy biomarker. |
| Molecular mechanism: |
Not specified; reported as elevated exosomal/tissue biomarker derived from post-transcriptional backsplicing of PTPN22. |
| Biological pathway or process: |
immune regulation (other) |
| Detected method: |
Q
S
|
| Validation methods: |
RNA-seq; RT-qPCR; Sanger Sequencing; RNase R Treatment; Back-Splice Junction PCR / divergent primers PCR; Clinical Sample Validation; Bioinformatics Analysis |
| Clinical significance: |
Elevated in ICC tumor tissues and plasma exosomes of an immunogenic Asian ICC subgroup; potential liquid biopsy biomarker. |
| Description: |
circ-PTPN22 is up-regulated in an immunogenic Asian ICC subgroup (subgroup 2) and is elevated in both tumor tissues and plasma exosomes, marking T cell exhaustion and neutrophil extracellular traps. The study validates its circular nature and upregulation by qRT-PCR, Sanger sequencing of the back-splice junction, and RNase R resistance, supporting its potential as a liquid-biopsy biomarker. |
| Confidence score: |
0.6193 |